High-dose vitamin E supplementation in phenytoin-induced intrauterine hypoxia: Teratological study

Biologia - Section Cellular and Molecular Biology

Volumn 60, Issue SUPPL. 17, 2005, Pages 45-49

  Mach, Mojmír ^a   Ujházy, Eduard ^a   Dubovický, Michal ^a   Kovačovsky, Pavel ^b   Navarová, Jana ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

Intrauterine hypoxia; Phenytoin; Rat; Teratology; Vitamin E

Indexed keywords

EID: 33751325836     PISSN: 13356399     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. AZARBAYJANI, F. & DANIELSSON, B.R. 1998. Pharmacologically induced embryonic dysrhythmia and episodes of hypoxia followed by reoxygenation: A common teratogenic mechanism for antiepileptic drugs? Teratology 57: 117-126.
2. BREINL, H., ANDRZEJEWSKI, C. & TONUTTI, E. 1967. Zur Feinstruktur der lutein Zellen des laktations Gelbkörpers der Ratte. Z. Mikrosk. Anat. Forsch. 77: 442-452.
3. BRIGELIUS-FLOHE, R., KELLY, F.J., SALONEN, J.T., NEUZIL, J., ZINGG, J.M. & AZZI, A. 2002. The European perspective on vitamin E: current knowledge and future research. Am. J. Clin. Nutr. 76: 703-716.
4. BRUCKNEROVÁ, I. & BENEDEKOVÁ, M. 2000. Asphyxia of the newborn - the ever topical problem. Biologia, Bratislava 55 (Suppl. 8): 23-26.
5. COHEN-KEREM, R. & KOREN, G. 2003. Antioxidants and fetal protection against ethanol teratogenicity. I. Review of the experimental data and implications to humans. Neurotoxicol. Teratol. 25:1-9.
6. DANIELSSON, B. R., AZARBAYJANI, F., SKOLD, A.C. & WEBSTER, W.S. 1997. Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation. Teratology 4: 271-281.
7. GITTO, E., REITEK, R.J., KABBOWNIK, M., TAN, D.X., GITTO, P., BAUBERI, S. & BARBERI, I. 2002. Causes of oxidative stress in the pre- and perinatal period. Biol. Neonate 81:14-57.
8. HANSON, J.W. & SMITH, D.W. 1975. The fetal hydantoin syndrom. J. Pediatr. 87: 285-290.
9. HARBISON, R.D. & BECKER, B.A. 1972. Diphenylhydantoin teratogenicity in rats. Toxicol. Appl. Pharmacol. 22: 193-200.
10. KAPPUS, H. & DIPLOCK, A.T. 1992. Tolerance and safety of vitamin E: a toxicological position report. Free Radic. Biol. Med. 13:55-74.
11. KAVLOCK, R.J., CHERNOFF, N. & ROGERS, E.H. 1985. The effect of acute maternal toxicity on fetal development in the mouse. Teratogen. Carcinogen. Mutagen. 5: 3-13.
12. KHERA, K.S. 1984. Maternal toxicity - a possible factor in fetal malformations in mice. Teratology 29: 411-416.
13. KIMMEL, C.A. & WILSON, J.G. 1973. Skeletal deviations in rats: malformations or variations? Teratology 8: 309-315.
14. LORKE, D. 1977. Evaluation of skeleton, pp 145-152. In: NEUBERT, D., MERKER, H.J. & KWASIGROCH, T.E. (eds) Methods in Prenatal Toxicology, G. Thieme, Stuttgart.
15. MANSON, J.M. & KANG, Y.J. 1989. Test methods for assessing female reproductive and developmental toxicology, pp. 311-359. In: HAVES, A.W. (ed.) Principles and Methods in Toxicology, Raven Press, New York.
16. MASSEY, K.M. 1966. Teratogenic effects of diphenylhydantoin sodium. J. Oral. Then Pharmacol. 2: 380-385.
17. NAVAROVA, J., UJHÁZY, E., DUBOVICKÝ, M. & MACH, M. 2004. Effect of melatonin on biochemical variables induced by phenytoin in organs of mothers, foetuses and offspring of rats. Central Eur. J. Public Health 12 (Suppl.): 67-69.
18. NAVAROVÁ, J., UJHÁZY, E., DUBOVICKÝ, M. & MACH, M. 2005. Phenytoin administration in pregnancy - effect of antioxidants on biochemical variables in pre- and postnatal development of rats. Biologia, Bratislava 60 (Suppl. 17): 51-55.
19. PALMER, A.K. 1977. Incidence of sporadic malformations, anomalies and variations in random bred laboratory animals, pp. 52-71. In: NEUDERT, D., MERKER, H.J. & KWASIGROCH, T.E. (eds) Methods in Prenatal Toxicology, G. Thieme, Stuttgart.
20. SIMÁN, C.M. & ERIKSSON, U.J. 1997. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 46:1054-1061.
21. UJHÁZY, E., DUBOVICKÝ, M., MACH, M., JURÁNEK, I., NAVAROVÁ, J., SADLOŇOVÁ, I. & GAJDOŠÍK, A. 2000. Effect of phenytoin on prenatal and postnatal development of rats. Biologia, Bratislava 55 (Suppl. 8): 125-130.
22. UJHÁZY, E., MACH, M., DUBOVICKÝ, M., NAVAROVA, J., BRUCKNEROVÁ, I. & JURÁNEK, I. 2005 Effect of pyridoindole stobadine on maternal and embryo-foetal toxicity induced by phenytoin in rats. Biologia, Bratislava 60 (Suppl. 17): 57-60.
23. VIANA, M., CASTRO, M., BARBAS, C., HERRERA, E. & BONET, B. 2003. Effect of different doses of vitamin E on the incidence of malformations in pregnant diabetic rats. Ann. Nutr. Metab. 47: 6-10.
24. VIANA, M., HERRERA, E. & BONET, B. 1996. Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E. Diabetologia 39:1041-1046.
25. VORHEES, C.V. 1987. Fetal hydantoin syndrome in rats: dose-effect relationship of prenatal phenytoin on postnatal development and behavior. Teratology 35: 287-303.
26. WELLS, P.G. & WINN, L.M. 1996. Biochemical toxicology of chemical teratogenesis. Crit. Rev. Biochem. Mol. 31: 1-40.